MaltSci 麦伴科研

Appearance

Popular Reports / microbiology

This report is written by MaltSci based on the latest literature and research findings

How do antibiotic resistance mechanisms develop? ​

Abstract ​

Antibiotic resistance has emerged as a pressing public health crisis, complicating the treatment of infections and threatening the efficacy of existing antibiotics. The mechanisms through which bacteria develop resistance are diverse and involve genetic mutations, horizontal gene transfer, and biofilm formation, all influenced by environmental and clinical factors. Genetic mutations can alter drug target sites or enable enzymatic degradation of antibiotics, while horizontal gene transfer allows for the rapid dissemination of resistance traits among bacterial populations. Biofilms, structured communities of bacteria, further complicate treatment by providing a protective environment against antibiotics. The misuse and overuse of antibiotics in healthcare and agriculture exert selective pressure, driving the evolution of resistant strains. This review systematically explores the pathways of antibiotic resistance development, emphasizing the importance of understanding these mechanisms for effective therapeutic strategies. Strategies to combat resistance include antibiotic stewardship programs, the development of novel antibiotics, and alternative therapies. Future research should focus on understanding resistance mechanisms at the molecular level and enhancing surveillance to monitor resistance patterns. By elucidating these processes, we can inform public health policies and clinical practices aimed at mitigating the spread of antibiotic resistance and preserving the effectiveness of antibiotic therapies.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Mechanisms of Antibiotic Resistance
    • 2.1 Genetic Mutations
    • 2.2 Horizontal Gene Transfer
    • 2.3 Biofilm Formation
  • 3 Environmental and Clinical Factors Influencing Resistance
    • 3.1 Selective Pressure from Antibiotic Use
    • 3.2 Role of Agriculture in Resistance Development
  • 4 Strategies to Combat Antibiotic Resistance
    • 4.1 Antibiotic Stewardship Programs
    • 4.2 Development of Novel Antibiotics and Alternatives
  • 5 Future Directions and Research Needs
    • 5.1 Understanding Resistance Mechanisms at the Molecular Level
    • 5.2 Surveillance and Monitoring of Resistance Patterns
  • 6 Conclusion

1 Introduction ​

Antibiotic resistance has emerged as a critical public health crisis, representing one of the most formidable challenges to modern medicine. The increasing prevalence of antibiotic-resistant bacteria not only complicates the treatment of common infections but also leads to higher medical costs, prolonged hospital stays, and increased mortality rates [1][2]. The World Health Organization has warned that we are approaching a "post-antibiotic era," where common infections and minor injuries could once again become fatal [3]. Understanding the mechanisms by which bacteria develop resistance is paramount for the development of effective therapeutic strategies and for the preservation of existing antibiotics.

The mechanisms of antibiotic resistance are multifaceted and involve a complex interplay of genetic, biochemical, and environmental factors. Bacteria can acquire resistance through genetic mutations, horizontal gene transfer, and biofilm formation, among other mechanisms [2][4]. These processes allow bacteria to survive in the presence of antibiotics, leading to the emergence of multidrug-resistant strains that pose significant treatment challenges. Moreover, the misuse and overuse of antibiotics in both healthcare and agricultural settings exert selective pressure on bacterial populations, further driving the evolution of resistance [1][2]. The role of environmental factors, such as pollution and antibiotic residues, also contributes to the dynamics of resistance development [5].

Research has shown that the evolution of antibiotic resistance is not a linear process but rather a complex phenomenon influenced by various selective pressures [2][3]. For instance, genetic plasticity enables bacteria to rapidly adapt by acquiring new resistance genes from their environment or through mutations that confer survival advantages [4][6]. Furthermore, biofilms can protect bacterial communities from antibiotic exposure, making infections harder to treat [4]. The understanding of these mechanisms is essential for devising new interventions and strategies to combat antibiotic resistance effectively.

This review will systematically explore the pathways through which antibiotic resistance mechanisms evolve. In the second section, we will discuss the primary mechanisms of antibiotic resistance, including genetic mutations, horizontal gene transfer, and biofilm formation. The third section will delve into the environmental and clinical factors influencing resistance, highlighting the role of selective pressure from antibiotic use and the impact of agricultural practices. The fourth section will outline strategies to combat antibiotic resistance, focusing on antibiotic stewardship programs and the development of novel antibiotics and alternatives. Finally, we will conclude by discussing future directions and research needs, emphasizing the importance of understanding resistance mechanisms at the molecular level and the necessity for surveillance and monitoring of resistance patterns.

By elucidating these mechanisms, this review aims to provide insights that can inform public health policies and clinical practices aimed at mitigating the spread of antibiotic resistance, ultimately safeguarding public health and enhancing the efficacy of antibiotic therapies. The ongoing battle against antibiotic resistance requires a comprehensive understanding of its underlying mechanisms and a concerted effort across multiple sectors to address this global health challenge effectively.

2 Mechanisms of Antibiotic Resistance ​

2.1 Genetic Mutations ​

Antibiotic resistance mechanisms develop through a variety of genetic mutations and adaptive processes that enable bacteria to survive in the presence of antimicrobial agents. These mechanisms can arise through both chromosomal mutations and the acquisition of exogenous resistance genes, often influenced by selective pressures from antibiotic use.

One primary mechanism of resistance is through genetic mutations, which can occur in genes encoding essential cellular functions. Such mutations may be detrimental in the absence of antibiotics, but they can confer a survival advantage when exposed to these drugs. For instance, resistance mutations typically arise in critical genes, and bacteria can mitigate the fitness costs associated with these mutations by acquiring compensatory mutations that restore their reproductive fitness in antibiotic-free environments [7].

Bacteria are capable of rapidly adapting to antibiotic pressure, primarily through two genetic mechanisms: mutation and horizontal gene transfer. Mutations can lead to alterations in drug target sites, enzymatic inactivation of the drug, or prevention of drug access to its target. These genetic changes can occur spontaneously, especially in hypermutator strains that have elevated mutation rates due to defects in DNA repair mechanisms [8].

In addition to chromosomal mutations, antibiotic resistance can also arise through horizontal gene transfer, which involves the transfer of resistance genes between bacteria via mobile genetic elements such as plasmids. This process can rapidly disseminate resistance traits across bacterial populations, significantly complicating treatment options [9].

The emergence of antibiotic resistance is further exacerbated by environmental factors and the presence of subinhibitory concentrations of antibiotics, which can stimulate genetic variation and promote the development of resistant strains. For example, low-dose antibiotics can act as signals that unexpectedly promote bacterial growth while simultaneously selecting for resistant variants [10].

In summary, the development of antibiotic resistance mechanisms is a multifaceted process driven by genetic mutations and horizontal gene transfer, influenced by environmental pressures and the selective effects of antibiotic exposure. Understanding these mechanisms is crucial for devising effective strategies to combat antibiotic resistance and mitigate its impact on public health [3][11].

2.2 Horizontal Gene Transfer ​

Antibiotic resistance mechanisms develop through several pathways, with horizontal gene transfer (HGT) playing a crucial role in the dissemination of resistance genes among bacterial populations. HGT allows for the rapid acquisition of antibiotic resistance traits, which can significantly impact the evolution and adaptation of bacteria in response to antibiotic pressure.

HGT encompasses various mechanisms, including transformation, transduction, and conjugation. Transformation involves the uptake of free DNA from the environment by a bacterial cell, while transduction refers to the transfer of genetic material between bacteria via bacteriophages. Conjugation, on the other hand, involves direct cell-to-cell contact and the transfer of plasmids that often carry multiple antibiotic resistance genes. These mechanisms enable bacteria to share resistance traits, leading to the emergence of multi-drug resistant strains.

The importance of HGT in the spread of antibiotic resistance is underscored by the existence of mobile genetic elements such as plasmids and integrons. Integrons, in particular, are genetic structures that can capture and express antibiotic resistance genes, facilitating their horizontal transfer. They are often found in multi-drug resistant strains isolated from both humans and animals, and their ability to cluster resistance genes enhances the efficiency of gene transfer [12].

Research indicates that the selective pressure exerted by antibiotic use is a significant driving force behind the evolution of resistance mechanisms. For instance, the presence of sub-inhibitory concentrations of antibiotics can promote the horizontal transfer of antibiotic resistance genes, further complicating efforts to manage antibiotic resistance [13]. Additionally, environmental factors, such as the presence of non-antibiotic compounds, can also accelerate the horizontal transfer of antibiotic resistance genes, which highlights the complexity of the mechanisms involved in resistance development [14].

Furthermore, acquired antibiotic resistance can arise through genetic mutations that alter the drug target sites, enzymatically inactivate the drug, or prevent the drug from accessing its target. These genetic changes can lead to heritable resistance, further emphasizing the dynamic nature of bacterial adaptation [15].

In summary, the development of antibiotic resistance mechanisms is a multifaceted process primarily driven by horizontal gene transfer, which facilitates the rapid spread of resistance genes among bacterial populations. The interplay of various genetic mechanisms, selective pressures from antibiotic use, and environmental factors contribute to the complexity of this public health challenge.

2.3 Biofilm Formation ​

Biofilm formation is a significant contributor to the development of antibiotic resistance mechanisms in bacteria. The complexity of biofilms, which are structured communities of bacteria embedded in a self-produced extracellular matrix, plays a critical role in enhancing bacterial resistance to antimicrobial agents. The formation of biofilms is a multifaceted process that involves various factors, leading to unique environments that confer tolerance and resistance to antibiotics.

Within biofilms, bacteria are embedded in an extracellular matrix composed of proteins, extracellular DNA (eDNA), and polysaccharides. This matrix serves several functions, including protecting the bacterial cells from external threats such as antibiotics and host immune responses. The architecture of the biofilm can hinder the penetration of antibiotics, preventing them from reaching effective concentrations throughout the biofilm structure. This limited penetration is exacerbated by gradients of nutrients and oxygen within the biofilm, which create varying metabolic states among the bacterial cells, further contributing to antibiotic tolerance and persistence [16].

Moreover, biofilms can facilitate the development of antibiotic resistance through several mechanisms. For instance, the expression of efflux pumps can be induced in different regions of the biofilm, allowing bacteria to actively expel antimicrobial agents. Additionally, the close proximity of cells within a biofilm promotes horizontal gene transfer, enabling the sharing of resistance genes among bacteria [17]. The presence of eDNA within the biofilm can also play a role in this process, as it may serve as a medium for gene exchange, enhancing the spread of resistance traits [18].

The biofilm state not only provides a protective environment but also alters gene expression in bacteria, leading to the formation of persister cells—dormant variants that can survive antibiotic treatment. These persister cells can repopulate the biofilm once the antibiotic pressure is removed, perpetuating the cycle of resistance [19].

Research into the mechanisms of biofilm-associated antibiotic resistance has highlighted the need for innovative therapeutic strategies. Traditional antibiotics often fail against biofilm-embedded bacteria, prompting investigations into alternative approaches such as nanomaterials, quorum-sensing inhibitors, and CRISPR/Cas9 gene editing technologies to disrupt biofilm formation and enhance treatment efficacy [20][21]. These strategies aim to target the unique characteristics of biofilms and their resistance mechanisms, ultimately improving outcomes for infections caused by biofilm-forming bacteria.

In summary, biofilm formation significantly contributes to the development of antibiotic resistance through structural protection, altered metabolic states, and genetic exchange mechanisms. Understanding these processes is crucial for developing effective treatments against biofilm-associated infections and combating the growing threat of antibiotic resistance.

3 Environmental and Clinical Factors Influencing Resistance ​

3.1 Selective Pressure from Antibiotic Use ​

Antibiotic resistance mechanisms develop as a result of complex interactions between environmental and clinical factors, primarily driven by selective pressure from antibiotic use. The evolution and spread of antibiotic resistance are significantly influenced by the antibiotic pressure exerted in microbial environments. This selective pressure can occur even at low antibiotic concentrations, which can lead to differential growth rates among resistant bacterial variants [22]. When multiple antibiotics are present, fluctuating selective pressures can result in the selection of bacterial variants that utilize various mechanisms of resistance, thereby enhancing their survival in variable conditions [22].

The primary mechanism through which antibiotic resistance arises is through mutation or horizontal gene transfer. Resistance can develop endogenously via mutation, as seen in Mycobacterium tuberculosis with rifampicin or in gonococci with benzylpenicillin, or exogenously through the transfer of resistance factors [23]. Mechanisms of resistance include decreased permeability to antibiotics, chemical modification of the drug, or alterations in the target site affinity [23].

Environmental factors also play a critical role in the emergence of antibiotic resistance. For instance, multidrug-resistant Gram-negative bacteria have increasingly become a significant challenge in infection control due to the co-selection of resistance genes in environments contaminated by antibiotics, animal waste, and pollutants [5]. These resistance genes can be naturally occurring or derived from anthropogenic sources, and they can co-select for mobile genetic elements carrying multiple resistance genes [5].

Moreover, the inappropriate use of antibiotics in clinical settings, agriculture, and veterinary practices creates a selective pressure that facilitates the emergence and spread of resistant bacteria [24]. This pressure is not limited to clinical environments; antibiotic pollution in natural ecosystems can exert selective pressures on bacteria, increasing the prevalence of resistance [25]. Research has shown that environmental concentrations of antibiotics can significantly inhibit wild-type bacterial populations, suggesting that both clinical and environmental antibiotic use contribute to resistance [25].

Additionally, it is important to note that antibiotic resistance can evolve even in the absence of antibiotic exposure, as some studies indicate that bacteria can develop resistance traits in response to other environmental stresses [26]. This underscores the complexity of resistance mechanisms and the various factors influencing their development.

In summary, the development of antibiotic resistance mechanisms is a multifaceted process influenced by selective pressures from both clinical and environmental antibiotic use. Understanding these dynamics is essential for developing effective strategies to combat antibiotic resistance and mitigate its impact on public health.

3.2 Role of Agriculture in Resistance Development ​

Antibiotic resistance mechanisms develop through a complex interplay of environmental and clinical factors, with significant contributions from agricultural practices. The evolution of antibiotic resistance is an ancient problem, deeply rooted in the co-evolution of antibiotic-producing organisms and their targets in various environments, particularly soil. The "environmental resistome" encompasses all genes that contribute to antibiotic resistance, many of which originate from antibiotic-producing organisms that have developed self-immunity mechanisms. These resistance genes can be mobilized and expressed in non-native hosts, such as through plasmid-encoded β-lactamases, leading to the emergence of resistant pathogens in clinical settings [27].

Agricultural practices, particularly the indiscriminate use of antibiotics in livestock, create selective pressures that favor the development and dissemination of antimicrobial resistance. The mechanisms by which agricultural antibiotic use could lead to human disease include direct infection from resistant bacteria in animal sources, sustained transmission of resistant strains from livestock to humans, and the transfer of resistance genes from agricultural environments into human pathogens [28]. Evidence suggests that resistant bacteria originating from agricultural practices can enter the human population, posing a significant risk to public health [29].

Moreover, the agricultural ecosystem serves as a critical platform for the emergence of antibiotic resistance. The selective pressure from antibiotic use in veterinary and agricultural contexts leads to the development of both intrinsic and extrinsic resistance in bacterial populations. This phenomenon is particularly pronounced within the interconnected nexus of aquaculture, animal husbandry, manure management, soil, water, and plant systems [29]. Studies have documented the existence of antimicrobial resistance in environmental contexts, but the transmission routes of resistance genes between agricultural and human environments remain poorly understood [29].

In clinical settings, the rise of antibiotic-resistant pathogens has been linked to environmental reservoirs of resistance genes, which can be influenced by anthropogenic activities. The transmission of resistance genes from the environment to clinical settings is increasingly recognized as a significant concern. The mechanisms of this transmission involve horizontal gene transfer and the persistence of resistant bacteria in various environmental niches [30]. Additionally, factors such as pollution, changes in land use, and antibiotic contamination can exacerbate the problem, facilitating the emergence and spread of resistance [31].

The role of agriculture in antibiotic resistance development underscores the necessity for integrated approaches to mitigate this public health crisis. Efforts must focus on reducing the use of antibiotics in agricultural practices, improving waste management, and understanding the dynamics of resistance gene transmission across different environments [30]. Furthermore, enhancing surveillance and implementing stringent regulations regarding antibiotic use in agriculture are critical steps toward controlling the spread of antibiotic resistance [32].

In conclusion, the development of antibiotic resistance mechanisms is a multifaceted issue influenced by environmental factors, clinical practices, and agricultural activities. Addressing this challenge requires a comprehensive understanding of the interconnectedness of these factors and collaborative efforts to mitigate the risks associated with antibiotic resistance.

4 Strategies to Combat Antibiotic Resistance ​

4.1 Antibiotic Stewardship Programs ​

Antibiotic resistance mechanisms develop through a variety of physiological and biochemical processes that enable bacteria to survive the effects of antibiotics. The evolution of antibiotic resistance is a complex interplay of genetic changes, selective pressures, and environmental factors.

One primary mechanism involves genetic mutations that alter the target sites of antibiotics, thereby diminishing the drugs' efficacy. For instance, alterations in the peptidyltransferase center of the bacterial ribosome can lead to reduced binding of antibiotics, resulting in resistance (McCusker & Fujimori, 2012) [33]. Additionally, bacteria can produce enzymes that degrade or modify antibiotics, further enhancing their survival against these therapeutic agents (Eichenberger & Thaden, 2019) [2].

Another significant contributor to antibiotic resistance is the phenomenon of horizontal gene transfer, where resistance genes are exchanged between bacteria, often through plasmids or transposons. This rapid dissemination of resistance traits can occur within bacterial populations, leading to the emergence of multidrug-resistant strains (Klemm et al., 2018) [34].

Moreover, epigenetic factors also play a role in resistance development. Research indicates that epigenetic modifications can influence mutation rates and contribute to the transient nature of antibiotic resistance (Ghosh et al., 2020) [35]. This suggests that resistance can be a dynamic trait, influenced by environmental stresses and antibiotic exposure.

The development of bacterial persister cells is another critical mechanism in chronic infections. These cells enter a dormant state, allowing them to survive antibiotic treatment. When conditions are favorable, they can repopulate, leading to recurrent infections and complicating treatment efforts (Kunnath et al., 2024) [36].

In response to the growing threat of antibiotic resistance, various strategies have been proposed to combat this issue. One essential approach is the implementation of antibiotic stewardship programs, which aim to optimize the use of antibiotics. These programs focus on educating healthcare providers about appropriate prescribing practices, promoting the judicious use of antibiotics, and monitoring resistance patterns to guide therapy (Shah et al., 2022) [37].

Furthermore, the development of new antibiotics and alternative therapeutic strategies is crucial. Research into novel compounds that target unique bacterial mechanisms or utilize bacteriophages and antimicrobial peptides offers promising avenues for overcoming resistance (Halawa et al., 2023) [38].

Additionally, enhancing public awareness regarding antibiotic use and resistance is vital. Encouraging responsible usage among both healthcare providers and patients can significantly reduce the selective pressure that drives the emergence of resistant strains.

In conclusion, understanding the multifaceted mechanisms behind antibiotic resistance is essential for developing effective strategies to combat this pressing global health threat. Implementing comprehensive antibiotic stewardship programs and investing in research for novel therapeutic options are critical steps in mitigating the impact of antibiotic resistance.

4.2 Development of Novel Antibiotics and Alternatives ​

Antibiotic resistance mechanisms develop through a variety of physiological and biochemical processes, which can be broadly categorized into intrinsic and acquired resistance. Intrinsic resistance is inherent to specific bacterial species, dictating their natural resistance to certain antibiotics due to their genetic makeup. In contrast, acquired resistance arises from genetic mutations or the acquisition of resistance genes through horizontal gene transfer, such as transformation, transduction, or conjugation. This acquired resistance can involve several mechanisms, including but not limited to antibiotic degradation, modification of drug targets, and alterations in membrane permeability that prevent antibiotic entry [2][36][39].

The development of antibiotic resistance is further influenced by environmental factors and the selective pressure exerted by antibiotic use. For instance, misuse and overuse of antibiotics can accelerate the evolution of resistance. Bacteria can enter a dormant state known as bacterial persistence, allowing them to survive high concentrations of antibiotics without being killed. This state is particularly relevant in chronic infections, where persister cells can give rise to offspring that carry antibiotic resistance traits [36].

Recent studies have highlighted the role of epigenetic modifications in resistance development, where changes in gene expression without alterations in the underlying DNA sequence can contribute to resistance. For example, methylation of nucleotides can influence mutation rates, thereby modulating antibiotic susceptibility [35]. Additionally, metabolic gene mutations can also drive resistance evolution, particularly in response to sub-inhibitory concentrations of antibiotics that may stimulate bacterial growth rather than inhibit it [10].

To combat antibiotic resistance, various strategies have been proposed. One approach involves the development of novel antibiotics that target unique bacterial pathways or utilize alternative mechanisms of action to bypass existing resistance. The identification of new drug targets, such as those involved in bacterial persistence or metabolic regulation, is critical [39][40]. Furthermore, antibiotic adjuvants, which enhance the efficacy of existing antibiotics by inhibiting resistance mechanisms (e.g., efflux pump inhibitors or β-lactamase inhibitors), are also being explored as potential solutions [41].

Moreover, understanding the genetic and evolutionary foundations of antibiotic resistance can inform the development of comprehensive strategies to mitigate its emergence. This includes implementing robust antimicrobial stewardship programs to minimize unnecessary antibiotic use and exploring alternative therapies, such as bacteriophage therapy or the use of immunomodulators [42][43].

In summary, antibiotic resistance mechanisms develop through complex interactions involving genetic mutations, horizontal gene transfer, and environmental pressures. Addressing this issue requires a multifaceted approach that includes the development of novel antibiotics, the use of adjuvants, and a deeper understanding of the genetic basis of resistance to inform treatment strategies.

5 Future Directions and Research Needs ​

5.1 Understanding Resistance Mechanisms at the Molecular Level ​

Antibiotic resistance mechanisms in bacteria are multifaceted and can arise through various genetic and biochemical processes. These mechanisms are crucial for bacterial survival in the presence of antibiotics and represent a significant challenge in clinical settings. The development of resistance can occur through several primary pathways, including target modification, enzymatic degradation, and active efflux of the antibiotic.

One major mechanism of resistance is the alteration of the antibiotic's target site within the bacterial cell. This can involve mutations in genes encoding proteins that serve as targets for antibiotics, thus reducing the drug's efficacy. For instance, modifications in the peptidoglycan synthesis pathway can confer resistance to β-lactam antibiotics, which target penicillin-binding proteins essential for bacterial cell wall integrity [4].

Enzymatic degradation is another prevalent mechanism, where bacteria produce enzymes that chemically modify or inactivate the antibiotic. A well-known example is the production of β-lactamases, enzymes that hydrolyze the β-lactam ring of penicillins and cephalosporins, rendering them ineffective [44]. This enzymatic resistance is often acquired through horizontal gene transfer, where resistance genes are exchanged between bacteria, leading to the rapid spread of resistance [2].

Active efflux pumps are also critical in antibiotic resistance. These membrane proteins actively transport antibiotics out of the bacterial cell, decreasing the intracellular concentration of the drug to sub-lethal levels. This mechanism is particularly significant in Gram-negative bacteria, where the outer membrane serves as an additional barrier to drug penetration [45].

The genetic basis for these resistance mechanisms is often linked to mutations in existing genes or the acquisition of new genetic material through processes such as transformation, transduction, or conjugation. For example, the SOS response pathway in bacteria can lead to hypermutation rates, facilitating the emergence of resistant strains [15]. Additionally, environmental factors and selective pressures can drive the evolution of resistance, as bacteria that can survive antibiotic exposure are more likely to reproduce and pass on their resistant traits [46].

Understanding these resistance mechanisms at a molecular level is vital for developing new therapeutic strategies. It requires comprehensive studies that not only focus on the genetic and biochemical pathways involved but also consider the environmental contexts in which resistance evolves. Future research needs to emphasize the identification of novel targets for antibiotics and the development of adjuvants that can restore the efficacy of existing antibiotics by inhibiting resistance mechanisms [41]. Moreover, advancements in genomic technologies can facilitate the tracking of resistance genes and their transmission among bacterial populations, providing critical insights into combating the growing threat of antibiotic resistance [47].

In summary, the development of antibiotic resistance mechanisms is a complex interplay of genetic adaptations, biochemical modifications, and environmental pressures. A deeper understanding of these processes is essential for devising effective interventions against antibiotic-resistant infections, which are increasingly threatening global health.

5.2 Surveillance and Monitoring of Resistance Patterns ​

Antibiotic resistance mechanisms develop through a variety of complex processes, primarily driven by genetic mutations and the acquisition of resistance genes. These mechanisms include antibiotic degradation, modification of antibiotic targets, and alterations in bacterial membrane permeability. The evolution of resistance can occur via de-novo mutations under selective pressure from antibiotic use or through horizontal gene transfer, where bacteria acquire mobile genetic elements that confer resistance. The latter often occurs in environments contaminated with antibiotics, where selective pressure favors the survival of resistant strains [2].

Understanding the dynamics of antibiotic resistance requires comprehensive surveillance and monitoring of resistance patterns. This is crucial for tracking the emergence and spread of resistant strains, which is increasingly recognized as a public health challenge. The development of advanced genotyping and next-generation sequencing technologies has significantly enhanced our ability to monitor resistance patterns in clinical settings. These technologies allow for the identification of specific resistance genes and their prevalence in various bacterial populations [48].

Future research should focus on several key areas to better combat antibiotic resistance. Firstly, there is a need for improved detection strategies that can quickly identify resistant strains in clinical and environmental settings. Innovative diagnostic methods that utilize electrostatic attraction, chemical reactions, and probe-free analyses are promising avenues for development [48]. Secondly, research should explore novel antimicrobial agents and treatment strategies, such as the use of biogenic silver nanoparticles and antimicrobial peptides, which have shown efficacy against resistant bacteria [48].

Furthermore, addressing the root causes of antibiotic resistance necessitates a multifaceted approach that includes educating healthcare providers about appropriate antibiotic use and implementing stricter regulations on antibiotic prescriptions in both human and veterinary medicine [45]. Understanding the role of the natural environment in the emergence of resistance is also critical, as anthropogenic activities can contribute to the evolution and dissemination of resistance genes [5].

In conclusion, the development of antibiotic resistance mechanisms is a dynamic process influenced by genetic factors, environmental conditions, and human activities. Future directions in research should prioritize surveillance and monitoring of resistance patterns, innovative detection methods, and the development of new therapeutic approaches to mitigate the growing threat of antibiotic-resistant infections [4][38].

6 Conclusion ​

The development of antibiotic resistance mechanisms is a complex and multifaceted issue that poses significant challenges to public health. This review highlights several key findings: first, antibiotic resistance arises from genetic mutations, horizontal gene transfer, and biofilm formation, all of which are influenced by selective pressures from antibiotic use in both clinical and agricultural settings. Second, environmental factors, including pollution and the presence of subinhibitory antibiotic concentrations, play a crucial role in promoting resistance. Third, understanding these mechanisms is vital for developing effective interventions, such as antibiotic stewardship programs and novel therapeutic strategies. As antibiotic resistance continues to evolve, future research must focus on elucidating the molecular mechanisms of resistance, enhancing surveillance and monitoring of resistance patterns, and exploring alternative treatment modalities. A collaborative, interdisciplinary approach will be essential to mitigate the threat of antibiotic resistance and safeguard public health.

References ​

  • [1] Syeda Fatima Nadeem;Umar Farooq Gohar;Syed Fahad Tahir;Hamid Mukhtar;Soisuda Pornpukdeewattana;Pikunthong Nukthamna;Ali Muhammed Moula Ali;Sri Charan Bindu Bavisetty;Salvatore Massa. Antimicrobial resistance: more than 70 years of war between humans and bacteria.. Critical reviews in microbiology(IF=5.1). 2020. PMID:32954887. DOI: 10.1080/1040841X.2020.1813687.
  • [2] Emily M Eichenberger;Joshua T Thaden. Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria.. Antibiotics (Basel, Switzerland)(IF=4.6). 2019. PMID:30959901. DOI: 10.3390/antibiotics8020037.
  • [3] Chowdhury M Hasan;Debprasad Dutta;An N T Nguyen. Revisiting Antibiotic Resistance: Mechanistic Foundations to Evolutionary Outlook.. Antibiotics (Basel, Switzerland)(IF=4.6). 2021. PMID:35052917. DOI: 10.3390/antibiotics11010040.
  • [4] Michela Galgano;Francesco Pellegrini;Elisabetta Catalano;Loredana Capozzi;Laura Del Sambro;Alessio Sposato;Maria Stella Lucente;Violetta Iris Vasinioti;Cristiana Catella;Amienwanlen Eugene Odigie;Maria Tempesta;Annamaria Pratelli;Paolo Capozza. Acquired Bacterial Resistance to Antibiotics and Resistance Genes: From Past to Future.. Antibiotics (Basel, Switzerland)(IF=4.6). 2025. PMID:40149034. DOI: 10.3390/antibiotics14030222.
  • [5] Elizabeth M H Wellington;Alistair B Boxall;Paul Cross;Edward J Feil;William H Gaze;Peter M Hawkey;Ashley S Johnson-Rollings;Davey L Jones;Nicholas M Lee;Wilfred Otten;Christopher M Thomas;A Prysor Williams. The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria.. The Lancet. Infectious diseases(IF=31.0). 2013. PMID:23347633. DOI: .
  • [6] Maria Miragaia. Factors Contributing to the Evolution of mecA-Mediated β-lactam Resistance in Staphylococci: Update and New Insights From Whole Genome Sequencing (WGS).. Frontiers in microbiology(IF=4.5). 2018. PMID:30483235. DOI: 10.3389/fmicb.2018.02723.
  • [7] Paulo Durão;Roberto Balbontín;Isabel Gordo. Evolutionary Mechanisms Shaping the Maintenance of Antibiotic Resistance.. Trends in microbiology(IF=14.9). 2018. PMID:29439838. DOI: 10.1016/j.tim.2018.01.005.
  • [8] N Woodford;M J Ellington. The emergence of antibiotic resistance by mutation.. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases(IF=8.5). 2007. PMID:17184282. DOI: 10.1111/j.1469-0691.2006.01492.x.
  • [9] D Mazel;J Davies. Antibiotic resistance in microbes.. Cellular and molecular life sciences : CMLS(IF=6.2). 1999. PMID:11212334. DOI: 10.1007/s000180050021.
  • [10] Hui Lin;Donglin Wang;Qiaojuan Wang;Jie Mao;Lutong Yang;Yaohui Bai;Jiuhui Qu. Epigenetic modifications and metabolic gene mutations drive resistance evolution in response to stimulatory antibiotics.. Molecular systems biology(IF=7.7). 2025. PMID:39820016. DOI: 10.1038/s44320-025-00087-4.
  • [11] Jessica M A Blair;Mark A Webber;Alison J Baylay;David O Ogbolu;Laura J V Piddock. Molecular mechanisms of antibiotic resistance.. Nature reviews. Microbiology(IF=103.3). 2015. PMID:25435309. DOI: 10.1038/nrmicro3380.
  • [12] A Carattoli. Importance of integrons in the diffusion of resistance.. Veterinary research(IF=3.5). 2001. PMID:11432416. DOI: 10.1051/vetres:2001122.
  • [13] Shuyao Zhu;Bingqing Yang;Zhiqiang Wang;Yuan Liu. Augmented dissemination of antibiotic resistance elicited by non-antibiotic factors.. Ecotoxicology and environmental safety(IF=6.1). 2023. PMID:37327521. DOI: 10.1016/j.ecoenv.2023.115124.
  • [14] Yuan Liu;Ziwen Tong;Jingru Shi;Yuqian Jia;Kangni Yang;Zhiqiang Wang. Correlation between Exogenous Compounds and the Horizontal Transfer of Plasmid-Borne Antibiotic Resistance Genes.. Microorganisms(IF=4.2). 2020. PMID:32784449. DOI: 10.3390/microorganisms8081211.
  • [15] Matthew J Culyba;Charlie Y Mo;Rahul M Kohli. Targets for Combating the Evolution of Acquired Antibiotic Resistance.. Biochemistry(IF=3.0). 2015. PMID:26016604. DOI: 10.1021/acs.biochem.5b00109.
  • [16] Cristina Uruén;Gema Chopo-Escuin;Jan Tommassen;Raúl C Mainar-Jaime;Jesús Arenas. Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance.. Antibiotics (Basel, Switzerland)(IF=4.6). 2020. PMID:33374551. DOI: 10.3390/antibiotics10010003.
  • [17] Ramanathan Srinivasan;Sivasubramanian Santhakumari;Pandurangan Poonguzhali;Mani Geetha;Madhu Dyavaiah;Lin Xiangmin. Bacterial Biofilm Inhibition: A Focused Review on Recent Therapeutic Strategies for Combating the Biofilm Mediated Infections.. Frontiers in microbiology(IF=4.5). 2021. PMID:34054785. DOI: 10.3389/fmicb.2021.676458.
  • [18] Azna Zuberi;Nayeem Ahmad;Hafiz Ahmad;Mohd Saeed;Irfan Ahmad. Beyond antibiotics: CRISPR/Cas9 triumph over biofilm-associated antibiotic resistance infections.. Frontiers in cellular and infection microbiology(IF=4.8). 2024. PMID:39035353. DOI: 10.3389/fcimb.2024.1408569.
  • [19] Kashish Azeem;Sadaf Fatima;Asghar Ali;Ayesha Ubaid;Fohad Mabood Husain;Mohammad Abid. Biochemistry of Bacterial Biofilm: Insights into Antibiotic Resistance Mechanisms and Therapeutic Intervention.. Life (Basel, Switzerland)(IF=3.4). 2025. PMID:39859989. DOI: 10.3390/life15010049.
  • [20] Yogesh Dutt;Ruby Dhiman;Tanya Singh;Arpana Vibhuti;Archana Gupta;Ramendra Pati Pandey;V Samuel Raj;Chung-Ming Chang;Anjali Priyadarshini. The Association between Biofilm Formation and Antimicrobial Resistance with Possible Ingenious Bio-Remedial Approaches.. Antibiotics (Basel, Switzerland)(IF=4.6). 2022. PMID:35884186. DOI: 10.3390/antibiotics11070930.
  • [21] Rasha Mohamed Hassan;Mohamed Samir Abd El-Maksoud;Iman Ahmed Youssef Ghannam;Aida Abdel-Sattar El-Azzouny;Mohamed Nabil Aboul-Enein. Synthetic non-toxic anti-biofilm agents as a strategy in combating bacterial resistance.. European journal of medicinal chemistry(IF=5.9). 2023. PMID:37866335. DOI: 10.1016/j.ejmech.2023.115867.
  • [22] F Baquero;M C Negri;M I Morosini;J Blázquez. Antibiotic-selective environments.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America(IF=7.3). 1998. PMID:9710666. DOI: 10.1086/514916.
  • [23] J M Hamilton-Miller. The emergence of antibiotic resistance: myths and facts in clinical practice.. Intensive care medicine(IF=21.2). 1990. PMID:2289992. DOI: 10.1007/BF01709702.
  • [24] Lucia Pallecchi;Alessandro Bartoloni;Franco Paradisi;Gian Maria Rossolini. Antibiotic resistance in the absence of antimicrobial use: mechanisms and implications.. Expert review of anti-infective therapy(IF=3.8). 2008. PMID:18847408. DOI: 10.1586/14787210.6.5.725.
  • [25] Alfredo Tello;Brian Austin;Trevor C Telfer. Selective pressure of antibiotic pollution on bacteria of importance to public health.. Environmental health perspectives(IF=9.8). 2012. PMID:22571927. DOI: 10.1289/ehp.1104650.
  • [26] Anna Knöppel;Joakim Näsvall;Dan I Andersson. Evolution of Antibiotic Resistance without Antibiotic Exposure.. Antimicrobial agents and chemotherapy(IF=4.5). 2017. PMID:28893783. DOI: 10.1128/AAC.01495-17.
  • [27] Julie A Perry;Gerard D Wright. The antibiotic resistance "mobilome": searching for the link between environment and clinic.. Frontiers in microbiology(IF=4.5). 2013. PMID:23755047. DOI: 10.3389/fmicb.2013.00138.
  • [28] Qiuzhi Chang;Weike Wang;Gili Regev-Yochay;Marc Lipsitch;William P Hanage. Antibiotics in agriculture and the risk to human health: how worried should we be?. Evolutionary applications(IF=3.2). 2015. PMID:25861382. DOI: 10.1111/eva.12185.
  • [29] Chidozie D Iwu;Lise Korsten;Anthony I Okoh. The incidence of antibiotic resistance within and beyond the agricultural ecosystem: A concern for public health.. MicrobiologyOpen(IF=4.6). 2020. PMID:32710495. DOI: 10.1002/mbo3.1035.
  • [30] Nicholas Skandalis;Marlène Maeusli;Dimitris Papafotis;Sarah Miller;Bosul Lee;Ioannis Theologidis;Brian Luna. Environmental Spread of Antibiotic Resistance.. Antibiotics (Basel, Switzerland)(IF=4.6). 2021. PMID:34071771. DOI: 10.3390/antibiotics10060640.
  • [31] D G Joakim Larsson;Carl-Fredrik Flach. Antibiotic resistance in the environment.. Nature reviews. Microbiology(IF=103.3). 2022. PMID:34737424. DOI: 10.1038/s41579-021-00649-x.
  • [32] Ruihao Xiao;Danlian Huang;Li Du;Biao Song;Lingshi Yin;Yashi Chen;Lan Gao;Ruijin Li;Hai Huang;Guangming Zeng. Antibiotic resistance in soil-plant systems: A review of the source, dissemination, influence factors, and potential exposure risks.. The Science of the total environment(IF=8.0). 2023. PMID:36708845. DOI: 10.1016/j.scitotenv.2023.161855.
  • [33] Kevin P McCusker;Danica Galonić Fujimori. The chemistry of peptidyltransferase center-targeted antibiotics: enzymatic resistance and approaches to countering resistance.. ACS chemical biology(IF=3.8). 2012. PMID:22208312. DOI: 10.1021/cb200418f.
  • [34] Elizabeth J Klemm;Vanessa K Wong;Gordon Dougan. Emergence of dominant multidrug-resistant bacterial clades: Lessons from history and whole-genome sequencing.. Proceedings of the National Academy of Sciences of the United States of America(IF=9.1). 2018. PMID:30559200. DOI: 10.1073/pnas.1717162115.
  • [35] Dipannita Ghosh;Balaji Veeraraghavan;Ravikrishnan Elangovan;Perumal Vivekanandan. Antibiotic Resistance and Epigenetics: More to It than Meets the Eye.. Antimicrobial agents and chemotherapy(IF=4.5). 2020. PMID:31740560. DOI: 10.1128/AAC.02225-19.
  • [36] Anil Philip Kunnath;Mohamed Suodha Suoodh;Dinesh Kumar Chellappan;Jestin Chellian;Kishneth Palaniveloo. Bacterial Persister Cells and Development of Antibiotic Resistance in Chronic Infections: An Update.. British journal of biomedical science(IF=4.6). 2024. PMID:39170669. DOI: 10.3389/bjbs.2024.12958.
  • [37] Radhika A Shah;Joanne I Hsu;Ravi R Patel;Uyen Ngoc Mui;Stephen K Tyring. Antibiotic resistance in dermatology: The scope of the problem and strategies to address it.. Journal of the American Academy of Dermatology(IF=11.8). 2022. PMID:34555484. DOI: 10.1016/j.jaad.2021.09.024.
  • [38] Esraa M Halawa;Mohamed Fadel;Mohammed W Al-Rabia;Ali Behairy;Nehal A Nouh;Mohamed Abdo;Rada Olga;Liana Fericean;Ahmed M Atwa;Mohammad El-Nablaway;Ahmed Abdeen. Antibiotic action and resistance: updated review of mechanisms, spread, influencing factors, and alternative approaches for combating resistance.. Frontiers in pharmacology(IF=4.8). 2023. PMID:38283841. DOI: 10.3389/fphar.2023.1305294.
  • [39] Sevan Gholipour;Dongkyu Lee;Nobuhiko Tokuriki. Molecular Evolution and Origins of Antibiotic Resistance Genes.. Biochemistry(IF=3.0). 2025. PMID:40457171. DOI: 10.1021/acs.biochem.5c00044.
  • [40] Joshua M B Johnson;Barbara N Kunkel. AefR, a TetR Family Transcriptional Repressor, Regulates Several Auxin Responses in Pseudomonas syringae Strain PtoDC3000.. Molecular plant-microbe interactions : MPMI(IF=3.4). 2024. PMID:38079389. DOI: 10.1094/MPMI-10-23-0170-R.
  • [41] Daniela Santos Pontes;Rodrigo Santos Aquino de Araujo;Natalina Dantas;Luciana Scotti;Marcus Tullius Scotti;Ricardo Olimpio de Moura;Francisco Jaime Bezerra Mendonca-Junior. Genetic Mechanisms of Antibiotic Resistance and the Role of Antibiotic Adjuvants.. Current topics in medicinal chemistry(IF=3.3). 2018. PMID:29412107. DOI: 10.2174/1568026618666180206095224.
  • [42] Bandar Ali Alghamdi;Intisar Al-Johani;Jawhra M Al-Shamrani;Hussein Musamed Alshamrani;Bandar G Al-Otaibi;Kholod Almazmomi;Nik Yusnoraini Yusof. Antimicrobial resistance in methicillin-resistant staphylococcus aureus.. Saudi journal of biological sciences(IF=4.4). 2023. PMID:36936699. DOI: 10.1016/j.sjbs.2023.103604.
  • [43] Brice Felden;Yoann Augagneur. Diversity and Versatility in Small RNA-Mediated Regulation in Bacterial Pathogens.. Frontiers in microbiology(IF=4.5). 2021. PMID:34447363. DOI: 10.3389/fmicb.2021.719977.
  • [44] Allison K Guitor;Gerard D Wright. Antimicrobial Resistance and Respiratory Infections.. Chest(IF=8.6). 2018. PMID:29959904. DOI: 10.1016/j.chest.2018.06.019.
  • [45] Avantika Mann;Kiran Nehra;J S Rana;Twinkle Dahiya. Antibiotic resistance in agriculture: Perspectives on upcoming strategies to overcome upsurge in resistance.. Current research in microbial sciences(IF=5.8). 2021. PMID:34841321. DOI: 10.1016/j.crmicr.2021.100030.
  • [46] Christopher J Skalnik;Sean Y Cheah;Mica Y Yang;Mattheus B Wolff;Ryan K Spangler;Lee Talman;Jerry H Morrison;Shayn M Peirce;Eran Agmon;Markus W Covert. Whole-cell modeling of E. coli colonies enables quantification of single-cell heterogeneity in antibiotic responses.. PLoS computational biology(IF=3.6). 2023. PMID:37327241. DOI: 10.1371/journal.pcbi.1011232.
  • [47] Gerard D Wright. Molecular mechanisms of antibiotic resistance.. Chemical communications (Cambridge, England)(IF=4.2). 2011. PMID:21286630. DOI: 10.1039/c0cc05111j.
  • [48] Kavya Moorthy;Kai-Chih Chang;Hsueh-Hui Yang;Wen-Min Su;Cheng-Kang Chiang;Zhiqin Yuan. Recent developments in detection and therapeutic approaches for antibiotic-resistant bacterial infections.. Journal of food and drug analysis(IF=3.0). 2023. PMID:37224551. DOI: 10.38212/2224-6614.3433.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

Antibiotic Resistance Mechanisms · Genetic Mutations · Horizontal Gene Transfer · Biofilm Formation · Antibiotic Stewardship

© 2025 MaltSci